Fibronectin (FN), epidermal growth factor-receptor (EGF-R) and heparin-binding epidermal growth factor-like (HB-EGF) urinary expressions and topical toxicity of adjuvant intravesical therapy for non muscle invasive bladder cancer (NMI-BC)
- Autori: Serretta, V.; Alonge, V.; Carità , G.; Scalici Gesolfo, C.; Caruso, S.; Fiorentino, E.; Russo, A.; Torretta, F.
- Anno di pubblicazione: 2014
- Tipologia: Proceedings (TIPOLOGIA NON ATTIVA)
- Parole Chiave: bladder cancer, BCG, fibronectin, markers
- OA Link: http://hdl.handle.net/10447/94777
Abstract
NMI bladder cancer, EGF-R, intravesical therapy. fibronectin